Japanese encephalitis virus monoclonal antibodies

Japanese encephalitis virus (JEV) is a Flavivirus spread by mosquitos in South-East Asia and the Western Pacific regions. Most infections cause little or no symptoms; however, occasional inflammation of the brain can occur. Mortality is highest in children but an effective vaccine is available.

ViroStat has released a new set of monoclonal antibodies to the NS1 protein of JEV. These antibodies do not cross-react with related viruses including yellow fever virus, West Nile virus, TBE virus, dengue viruses (1–4) and Zika virus. These antibodies form effective pairs for detecting the NS1 protein in enzyme-linked immunosorbent assay (ELISA) methods.

Data sheets of these new antibodies can be downloaded from the ViroStat website.

www.virostat-inc.com

 

Other news

Visualise No Malaria

Upcoming Events

Clinical and Laboratory Haemostasis 2019

The Atrium Conference Centre, Sheffield Hallam University
5-6 June 2019

Ist International Blizard/QMUL Tuberculosis Symposium

Bearsted Lecture Theatre, Alexandra Wing, Queen Mary University of London - Whitechapel
26-27 June 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Apr 2019

Reducing exposure to antimicrobial agents

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.